Gastrointestinal Cancers Symposium

Investigational Gastric Cancer Drug Elicits High Disease Control Rate
Investigational Gastric Cancer Drug Elicits High Disease Control Rate
Extensive Intraoperative Peritoneal Lavage May Not Improve Gastric Cancer Outcomes
Extensive Intraoperative Peritoneal Lavage May Not Improve Gastric Cancer Outcomes
Cabozantinib Improves Survival in Advanced Hepatocellular Carcinoma
Cabozantinib Improves Survival in Advanced Hepatocellular Carcinoma
Combination Therapy Shows Antitumor Activity in Advanced Gastric, GEJ Adenocarcinoma
Combination Therapy Shows Antitumor Activity in Advanced Gastric, GEJ Adenocarcinoma
Cyramza Added to Chemo Regimen Not Found to Improve Gastric Cancer Survival
Cyramza Added to Chemo Regimen Not Found to Improve Gastric Cancer Survival
Nivolumab Shows Promise Treating Gastrointestinal Tumors
Nivolumab Shows Promise Treating Gastrointestinal Tumors
Circulating Tumor Cell Test Effective Detecting Precancerous Lesions
Circulating Tumor Cell Test Effective Detecting Precancerous Lesions
Abraxane Plus Gemcitabine Shows Efficacy Treating Pancreatic Cancer
Abraxane Plus Gemcitabine Shows Efficacy Treating Pancreatic Cancer
Combo Therapy Well-Tolerate in RAS Wild-Type Metastatic Colorectal Cancer
Combo Therapy Well-Tolerate in RAS Wild-Type Metastatic Colorectal Cancer
Keytruda Improves Progression-Free Survival in Advanced Hepatocellular Carcinoma
Keytruda Improves Progression-Free Survival in Advanced Hepatocellular Carcinoma
What Should Specialty Pharmacists Know About the REVERCE Clinical Trial?
What Should Specialty Pharmacists Know About the REVERCE Clinical Trial?
What Should Specialty Pharmacists Know About the ReDOS Clinical Trial?
What Should Specialty Pharmacists Know About the ReDOS Clinical Trial?
+ Load More